April 29th 2024
The CDMO’s boost in production will be centered around pharmaceutical products.
April 25th 2024
The company adds a top-10 CDMO to its portfolio in the process, while also expanding its commitment to the pharma industry.
The deal further grows the Big Pharma company’s US production capabilities, especially when it comes to global parenteral products.
April 9th 2024
The acquisition initiates a long-term agreement with Beacon Therapeutics, highlighted by clinical and commercial AAV production.
March 22nd 2024
The purpose for the deal, the CDMO says, is to meet the demand for commercial mammalian contract manufacturing.
Bionova Scientific Begins Plant Expansion Project
CDMO is commissioning third GMP biologics facility in Fremont.
Vector BioMed Makes Company Debut
CDMO will be providing high-quality lentiviral vectors for CAR-T therapies.
Seqens Group Unveils R&D Center in Greater Boston
Location serves as the US flagship for company’s global pharma development network.
Construction of Mawdsleys’ $15M Temperature-Controlled Facility Now Underway
Project—which is expected to double plant’s distribution capacity—will be completed by end of Q3.
Catalent Completes Belgium Manufacturing Facility
Complex to develop cGMP-compliant, commercial-scale plasmid DNA.
Stevanato Group, Transcoject Collaborate on Pre-Fillable Syringe
Companies to release variety of options for this sector.
Lilly Financially Commits Additional $450M toward Research Triangle Park Facility
Expansion expected to help tackle health issues at a faster rate, company says
Colorcon Acquires Airnov Healthcare Packaging
Transaction expected to close early this year
TTP Reveals New Cell and Gene Therapy Organization
Creates Cellular Origins in order to simplify the late-stage development process
Pfizer Purchases Production Site from Abzena
North Carolina facility to manufacture Pfizer’s pipeline products
Upperton Pharma Solutions Begins Construction of GMP Facility
Nottingham location expected to be fully operational by the end of 2023
Charles River Introduces New Plasmid Manufacturing Program
Platform is expected to streamline batch turnaround times
Alora Pharmaceuticals Obtains Monarch Manufacturing Plant
Acquisition of Texas facility to add 60,000 square feet of manufacturing space to company’s footprint
Avantor and Catalent Ink Multi-year Supply and Services Deal
Provider will be CDMO’s primary material supplier in the lab, clinical, and production settings
Samsung Biologics Granted Terra Carta Seal
Award given in recognition of CDMO’s commitment to promoting sustainable future
SCHOTT Opens First US Manufacturing Facility
Phoenix location will be company’s first to focus on high-density microarrays for diagnostic and life science research
Viralgen Earns cGMP Certification at New Spanish Plant
CDMO will be able to produce rAAV commercial grade product
WuXi STA Introduces Oral Solid Continuous Manufacturing Line
Provides clientele with an augmented drug development solution
AmerisourceBergen Finalizes Billion-dollar Deal for PharmaLex
Provider’s regulatory affairs, pharmacovigilance services expected to help increase ABC’s portfolio
Companies Partner Up on Sustainable Pharma Packaging
Collaboration aims to decrease environmental burden in the space
BMS Finalizes Sale of East Syracuse Manufacturing Plant
Lotte Biologics will assume facility ownership, as CDMO joins pharma space with the acquisition
Berkshire Sterile Further Grows Its Instrument Collection
With the new additions, CDMO expands its analytical testing and development services
GSK, Sanofi, and Takeda Partner with Singapore on Biologics Innovation
Big Pharma to collaborate with researchers from A*STAR, along with Singapore universities
WuXi STA Unveils New Parenteral Formulation Manufacturing Line
Will further boost CDMO’s injectable drug product platform
Schreiner MediPharm, SCHOTT Introduce Prefilled Syringes Powered by RFID Labels
Can help facilitate digital identification of medications
MilliporeSigma Commits $286 Million toward US Biosafety Testing
Drug safety analysis to be conducted at Rockland, MD facility
WuXi Vaccines to Debut New Vaccines Facility in China
Plant will be CDMO’s first standalone GMP and vaccine development manufacturing site in the country
BioNTech Establishes APAC Regional Headquarters
Former Novartis plant will become mRNA manufacturing facility, the first in Singapore
Charles River Grows Memphis Facility
Manufacturing plant addition features nine new processing suites
BIOVECTRA Increases Manufacturing Services
New microbial fermentation tech expected to boost CDMO’s overall capacity